Stocks News

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Dec 3, 2024
- Immunocore Says UK NICE Recommends Kimmtrak for Funding Through National Health Service in England, from 9:15AM ET on Tuesday Dec 03, 2024 by MT Newswires
  9:15AM ET on Tuesday Dec 03, 2024 by MT Newswires
  Companies Mentioned: IMCR
  09:15 AM EST, 12/03/2024 (MT Newswires) -- Immunocore Holdings (IMCR) said Tuesday that the National Institute for Health and Care Excellence has recommended Kimmtrak for funding through the National Health Service in England. The National Institute...
- Immunocore announces reimbursement agreement in England for KIMMTRAK for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma, from 1:00AM ET on Tuesday Dec 03, 2024 by Dow Jones
  1:00AM ET on Tuesday Dec 03, 2024 by Dow Jones
  Companies Mentioned: IMCR
  
  Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on February 28, 2024, as well as discussions of potential risks, uncertainties, and other important factors in the Company's subsequent filings with the SEC. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information, except as required by law.
Nov 11, 2024
- --Mizuho Securities Downgrades Immunocore to Neutral From Outperform, $72 Price Target, from 8:36AM ET on Monday Nov 11, 2024 by MT Newswires
  8:36AM ET on Monday Nov 11, 2024 by MT Newswires
  Companies Mentioned: IMCR
  08:36 AM EST, 11/11/2024 (MT Newswires) -- ...
- DJ Immunocore Holdings Cut to Neutral From Outperform by Mizuho, from 6:50AM ET on Monday Nov 11, 2024 by Dow Jones
  6:50AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: IMCR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IMCR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 11, 2024 06:50 ET (11:50 GMT)
Nov 8, 2024
- Immunocore to present at upcoming investor conferences, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: IMCR
  
  Immunocore to present at upcoming investor conferences
  
  (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 8 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) ("Immunocore" or the "Company"), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that management will participate in the following investor conferences in November.

Dec 4, 2024
- --B. Riley Lowers Price Target on Harrow to $69 From $73, Maintains Buy Rating, from 7:44AM ET on Wednesday Dec 04, 2024 by MT Newswires
  7:44AM ET on Wednesday Dec 04, 2024 by MT Newswires
  Companies Mentioned: HROW
Nov 26, 2024
- Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference, from 4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones
  4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: KNSA
- Innoviva to Participate in the Citi 2024 Global Healthcare Conference, from 7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
  7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: INVA
Nov 21, 2024
- Harrow Says ImprimisRx Unit Wins Jury Verdict in Trademark Infringement Case, from 8:40AM ET on Thursday Nov 21, 2024 by MT Newswires
  8:40AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: HROW
- *DJ Harrow's ImprimisRx Subsidiary Receives $34.9M Unanimous Jury Verdict Award in Case Vs. OSRX Inc., from 7:03AM ET on Thursday Nov 21, 2024 by Dow Jones
  7:03AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: HROW
- Harrow's ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc., from 7:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  7:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: HROW
Nov 20, 2024
- Kiniksa Pharmaceuticals International Insider Sold Shares Worth $357,680, According to a Recent SEC Filing, from 4:43PM ET on Wednesday Nov 20, 2024 by MT Newswires
  4:43PM ET on Wednesday Nov 20, 2024 by MT Newswires
  Companies Mentioned: KNSA
- Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery, from 7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
  7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: HROW
Nov 15, 2024
- Harrow Announces Participation in Upcoming Investor Conferences, from 7:00AM ET on Friday Nov 15, 2024 by Dow Jones
  7:00AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: HROW
Nov 14, 2024
- DJ Harrow Down Nearly 13%, on Pace for Largest Percent Decrease Since November 2023 -- Data Talk, from 11:46AM ET on Thursday Nov 14, 2024 by Dow Jones
  11:46AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: HROW

Immunocore Holdings PLC
NASDAQ:IMCRUnited States

Search Criteria

Dec 3, 2024

Immunocore Says UK NICE Recommends Kimmtrak for Funding Through National Health Service in England, from 9:15AM ET on Tuesday Dec 03, 2024 by MT Newswires

Immunocore announces reimbursement agreement in England for KIMMTRAK for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma, from 1:00AM ET on Tuesday Dec 03, 2024 by Dow Jones

Nov 11, 2024

--Mizuho Securities Downgrades Immunocore to Neutral From Outperform, $72 Price Target, from 8:36AM ET on Monday Nov 11, 2024 by MT Newswires

DJ Immunocore Holdings Cut to Neutral From Outperform by Mizuho, from 6:50AM ET on Monday Nov 11, 2024 by Dow Jones

Nov 8, 2024

Immunocore to present at upcoming investor conferences, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones

Peers Headlines

Dec 4, 2024

--B. Riley Lowers Price Target on Harrow to $69 From $73, Maintains Buy Rating, from 7:44AM ET on Wednesday Dec 04, 2024 by MT Newswires

Nov 26, 2024

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference, from 4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones

Innoviva to Participate in the Citi 2024 Global Healthcare Conference, from 7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 21, 2024

Harrow Says ImprimisRx Unit Wins Jury Verdict in Trademark Infringement Case, from 8:40AM ET on Thursday Nov 21, 2024 by MT Newswires

*DJ Harrow's ImprimisRx Subsidiary Receives $34.9M Unanimous Jury Verdict Award in Case Vs. OSRX Inc., from 7:03AM ET on Thursday Nov 21, 2024 by Dow Jones

Harrow's ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc., from 7:00AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $357,680, According to a Recent SEC Filing, from 4:43PM ET on Wednesday Nov 20, 2024 by MT Newswires

Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery, from 7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 15, 2024

Harrow Announces Participation in Upcoming Investor Conferences, from 7:00AM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

DJ Harrow Down Nearly 13%, on Pace for Largest Percent Decrease Since November 2023 -- Data Talk, from 11:46AM ET on Thursday Nov 14, 2024 by Dow Jones